College of Medicine
Russ Lab
Led by Holger Russ · Pharmacology and Therapeutics
What we study
The Russ Lab studies autoimmune type 1 diabetes (T1D) using human stem cells and genome engineering to model and treat the disease. They focus on regenerative medicine and immune mechanisms.
What working here is like
- Wet lab
- Cells in a dish
- Projects
- 5
- Papers
- 2
Current projects
Microgels for localized immune control in beta cell replacement
Developing microgels to control immune responses in beta cell replacement therapy.
Development of a triple autologous organoid with thymic education capability
Creating organoids that mimic thymic function to treat autoimmune diseases.
Show 3 more projectsShow fewer
Interrogating the role of environmental and cellular factors in human T1D pathophysiology
Studying how environmental and cellular factors contribute to T1D development.
Co-Engineering Stem Cell-Derived Beta Cells and Regulatory T Cells to Treat Type 1 Diabetes
Combining stem cell-derived beta cells and regulatory T cells to treat T1D.
Engineered Nanocapsules for Targeted Drug Delivery to the ß-Cell
Designing nanocapsules to deliver drugs specifically to beta cells.
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
Recent papers, explained
- Physical and Biochemical Determinants of Endocrine Fate in 3D Suspension Culture Based Stem Cell-Derived β-Cell Differentiation
2026 · Cells
Studies how different factors affect the creation of insulin-producing cells from stem cells.
- Summary Report of the Fifth International Pancreas and Islet Transplant Association Summit on Stem Cell–derived Islets
2026 · Transplantation
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Holger Russ hasn't set up this page yet. You can also look them up in the UF directory (search “Holger Russ”).